Real-time enrollment status for this sarcoma clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 3:48 PM UTC
| NCT Number | NCT06422806 |
| Recruiting Status | Recruiting |
| Condition | Sarcoma |
| Phase | PHASE3 |
| Target Enrollment | 365 participants |
| Active Locations | 255 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | October 15, 2026 (Yesterday) |
As of October 16, 2026: Clinical trial NCT06422806 is currently recruiting participants. This phase3 study for sarcoma is actively seeking new participants at 255 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06422806 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 255 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06422806 was last updated Yesterday (October 15, 2026). HelloStudys verifies this status automatically.